1. Ahmed, F., A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection. Frontiers in immunology 2020, 11, 590459.
2. Lingeswaran, M.; Goyal, T.; Ghosh, R.; Suri, S.; Mitra, P.; Misra, S.; Sharma, P., Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review. Indian journal of clinical biochemistry : IJCB 2020, 35 (3), 260-273.
3. Mohamed, G. A.; Ibrahim, S. R. M.; El-Agamy, D. S.; Elsaed, W. M.; Sirwi, A.; Asfour, H. Z.; Koshak, A. E.; Elhady, S. S., Terretonin as a New Protective Agent against Sepsis-Induced Acute Lung Injury: Impact on SIRT1/Nrf2/NF-kappaBp65/NLRP3 Signaling. Biology (Basel) 2021, 10 (11).
4. Nie, Y.; Nirujogi, T. S.; Ranjan, R.; Reader, B. F.; Chung, S.; Ballinger, M. N.; Englert, J. A.; Christman, J. W.; Karpurapu, M., PolyADP-Ribosylation of NFATc3 and NF-kappaB Transcription Factors Modulate Macrophage Inflammatory Gene Expression in LPS-Induced Acute Lung Injury. J Innate Immun 2021, 13 (2), 83-93.
5. Liang, Y.; Yang, N.; Pan, G.; Jin, B.; Wang, S.; Ji, W., Elevated IL-33 promotes expression of MMP2 and MMP9 via activating STAT3 in alveolar macrophages during LPS-induced acute lung injury. Cell Mol Biol Lett 2018, 23, 52.
6. Szklarczyk, D.; Gable, A. L.; Nastou, K. C.; Lyon, D.; Kirsch, R.; Pyysalo, S.; Doncheva, N. T.; Legeay, M.; Fang, T.; Bork, P.; Jensen, L. J.; von Mering, C., The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res 2021, 49 (D1), D605-D612.
7. Korbecki, J.; Kupnicka, P.; Chlubek, M.; Gorący, J.; Gutowska, I.; Baranowska-Bosiacka, I., CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer. International Journal of Molecular Sciences 2022, 23 (4).
8. Hsing, C. H.; Wang, J. J., Clinical implication of perioperative inflammatory cytokine alteration. Acta Anaesthesiol Taiwan 2015, 53 (1), 23-8.
9. Gierlikowska, B.; Stachura, A.; Gierlikowski, W.; Demkow, U., The Impact of Cytokines on Neutrophils' Phagocytosis and NET Formation during Sepsis-A Review. Int J Mol Sci 2022, 23 (9).
10. Hsu, R. J.; Yu, W. C.; Peng, G. R.; Ye, C. H.; Hu, S.; Chong, P. C. T.; Yap, K. Y.; Lee, J. Y. C.; Lin, W. C.; Yu, S. H., The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Front Immunol 2022, 13, 832394.
11. Wang, Y.; Zhu, K.; Dai, R.; Li, R.; Li, M.; Lv, X.; Yu, Q., Specific Interleukin-1 Inhibitors, Specific Interleukin-6 Inhibitors, and GM-CSF Blockades for COVID-19 (at the Edge of Sepsis): A Systematic Review. Frontiers in pharmacology 2021, 12, 804250.
12. Jafarzadeh, A.; Chauhan, P.; Saha, B.; Jafarzadeh, S.; Nemati, M., Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life sciences 2020, 257, 118102.
13. Wang, J.; Shen, Y. C.; Chen, Z. N.; Yuan, Z. C.; Wang, H.; Li, D. J.; Liu, K.; Wen, F. Q., Microarray profiling of lung long non-coding RNAs and mRNAs in lipopolysaccharide-induced acute lung injury mouse model. Biosci Rep 2019, 39 (4).
14. Lu, W.; Ji, R., Identification of significant alteration genes, pathways and TFs induced by LPS in ARDS via bioinformatical analysis. BMC Infect Dis 2021, 21 (1), 852.
15. Wu, Y. H.; Wei, C. Y.; Hong, W. C.; Pang, J. S., Berberine Suppresses Leukocyte Adherence by Downregulating CX3CL1 Expression and Shedding and ADAM10 in Lipopolysaccharide-Stimulated Vascular Endothelial Cells. Int J Mol Sci 2022, 23 (9).
16. Wang, Y.; Pan, L., Knockdown of CXCL3-inhibited apoptosis and inflammation in lipopolysaccharide-treated BEAS-2B and HPAEC through inactivating MAPKs pathway. Allergologia et immunopathologia 2022, 50 (4), 10-16.
17. Lou, Y.; Huang, Z.; Wu, H.; Zhou, Y., Tranilast attenuates lipopolysaccharide‑induced lung injury via the CXCR4/JAK2/STAT3 signaling pathway. Molecular medicine reports 2022, 26 (1).
18. Root-Bernstein, R., Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions. International Journal of Molecular Sciences 2021, 22 (4).
19. Ding, X.; Tong, Y.; Jin, S.; Chen, Z.; Li, T.; Billiar, T. R.; Pitt, B. R.; Li, Q.; Zhang, L.-M., Mechanical ventilation enhances extrapulmonary sepsis-induced lung injury: role of WISP1-αvβ5 integrin pathway in TLR4-mediated inflammation and injury. Critical Care (London, England) 2018, 22 (1), 302.
20. Gao, N.; Liu, X.; Wu, J.; Li, J.; Dong, C.; Wu, X.; Xiao, X.; Yu, F.-S. X., CXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13. Angiogenesis 2017, 20 (4), 505-518.
21. Rappert, A.; Bechmann, I.; Pivneva, T.; Mahlo, J.; Biber, K.; Nolte, C.; Kovac, A. D.; Gerard, C.; Boddeke, H. W. G. M.; Nitsch, R.; Kettenmann, H., CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 2004, 24 (39), 8500-8509.
22. Iwamoto, H.; Izumi, K.; Mizokami, A., Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis? International Journal of Molecular Sciences 2020, 21 (23).
23. Bianchi, M. G.; Chiu, M.; Taurino, G.; Bergamaschi, E.; Cubadda, F.; Macaluso, G. M.; Bussolati, O., The TLR4/NFκB-Dependent Inflammatory Response Activated by LPS Is Inhibited in Human Macrophages Pre-Exposed to Amorphous Silica Nanoparticles. Nanomaterials (Basel, Switzerland) 2022, 12 (13).
24. Otto, M.; Dorn, B.; Grasmik, T.; Doll, M.; Meissner, M.; Jakob, T.; Hrgovic, I., Apremilast effectively inhibits TNFalpha-induced vascular inflammation in human endothelial cells. J Eur Acad Dermatol Venereol 2022, 36 (2), 237-246.
25. Sasaki, Y.; Arimochi, H.; Otsuka, K.; Kondo, H.; Tsukumo, S. I.; Yasutomo, K., Blockade of the CXCR3/CXCL10 axis ameliorates inflammation caused by immunoproteasome dysfunction. JCI Insight 2022, 7 (7).